Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide dismutase [Cu-Zn] (SOD1) is a critical antioxidant enzyme that catalyzes the dismutation of superoxide radicals into molecular oxygen and hydrogen peroxide, protecting cells from oxidative damage. Mutations in SOD1 are causative for some forms of familial amyotrophic lateral sclerosis (fALS). Overexpression has also been observed in various cancers.
Catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide Dismutase [Cu-Zn] (SOD1).